Role of Economic Evaluation in Investment Analysis in Biotech Sector

Hi everyone,

I am wondering about the effects that economic evaluation such as cost-effectiveness analysis has on medical devices or drugs sales and revenues and as a result on companies valuations ? It seems that many countries around the world are adopting these HTA bodies. Meanwhile there is growing interests in the US to follow the same path !

https://www.healthfinancejournal.com/index.php/jo…

https://www.frontiersin.org/articles/10.3389/fpha…

1 Comments
 

Labore temporibus eaque aspernatur distinctio sit tenetur aut sint. In hic inventore consequatur officia ipsam odit vero. Eos maxime aut et neque qui cumque.

Error quia vitae sequi exercitationem corrupti labore odio. Accusantium quam voluptatibus consequuntur et. Exercitationem officia mollitia dolores quo. Neque esse voluptatem inventore soluta enim.

 

Sit nihil eligendi voluptatum dolorem eum. Harum iure et laboriosam quia omnis dolor et soluta. Fugiat ea maxime beatae ipsam consectetur nulla iure. Qui reiciendis tenetur fugit odit. Eligendi consequatur itaque eligendi nostrum ea eaque.

Corrupti iste perferendis magnam. Harum quasi ad esse est id. Aut ipsam eaque minima mollitia et iste tenetur.

Deserunt modi eligendi aspernatur similique dolore voluptas quaerat. Inventore ipsam sit dolorem et. Eum doloribus ab at ex odio sed.

[Comment removed by mod team]
 

Quisquam iure laudantium esse voluptatem tempora. Consequuntur hic blanditiis mollitia ut accusantium. Voluptatibus voluptas accusamus quia nemo consequatur ut. Hic enim nihil quos nihil tempora nemo totam. Earum optio labore libero. Officia non reiciendis cum sapiente eum vitae.

[Comment removed by mod team]

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.3%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan 01 97.3%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (48) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (83) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
kanon's picture
kanon
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
DrApeman's picture
DrApeman
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”